Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 1079-1083

  Sakellariou, Stratigoula ^a,d   Liakakos, Theodore ^b   Ghiconti, Ioanna ^c   Hadjikokolis, Stamatis ^b   Nakopoulou, Lydia ^b   Pavlakis, Kitty ^b  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c AGIA OLGA HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Gastric cancer; Immunohistochemistry; P15; SMAD4

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; MONOCLONAL ANTIBODY; SMAD4 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME;

CYCLIN-DEPENDENT KINASE INHIBITOR P15; HUMANS; IMMUNOHISTOCHEMISTRY; SMAD4 PROTEIN; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 42549127791     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Stadtlander CT and Watebor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20: 2195-2208, 1999.
2. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics 1998. CA Cancer J Clin 48: 6-29, 1998.
3. Hoover RN: Cancer nature, nurture, or both. N Engl J Med 343: 135-136, 2000.
4. Huang JQ, Sridhar S, Chen Y and Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114: 1169-1179, 1998.
5. Shibata D and Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140: 769-774, 1992.
6. Bueso-Ramos C, Xu Y, McDonnell TJ, Brisbay S, Pierce S, Kantarjian H, Rosner G and Garcia-Manero G: Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has a prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol 23: 3932-3939, 2005.
7. Teofili L, Martini M, Luongo M, Diverio D, Capelli G, Breccia M, Lo Coco F, Leone G and Larocca LM: Hypermethylation of GpG islands in the promoter region of p15 (INK4b) in acute promyelocytic leukemia represses p15 (INK4b) expression and correlates with poor prognosis. Leukemia 17: 919-924, 2003.
8. Saxena A, Robertson JT and Ali IU: Abnormalities of p16, p15 and CDK4 genes in the recurrent malignant astrocytomas. Oncogene 13: 661-664, 1996.
9. Romanenko A, Morell-Quadreny L, Lopez-Guerrero JA, Pellin A, Nepomnyaschy V, Vozianov A and Llombart-Bosch A: P16 INK4A and INK4B gene alteration associated with oxidase stress in renal cell carcinomas after the Chernobyl accident (pilot study). Diagn Mol Pathol 11: 163-169, 2002.
10. Awaya H, Takeshima Y, Amatya VJ, Furonaka O, Tagawa K, Kohno N and Inai K: Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung. Pathol Int 54: 486-489, 2004.
11. Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, Go MY, Chung SC and Sung JJ: Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91: 2294-2301, 2001.
12. Wu MS, Shun CT, Sheu JC, Wang HP, Wang JT, Lee WJ, Chen CJ, Wang TH and Lin JT: Overexpression of mutant p53 and c-erbB 2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages. J Gastroenterol Hepatol 13: 305-310, 1998.
13. Lee YY, Kang SH, Seo JY, Jung CW, Lee KU, Choe KJ, Kim BK Kim NK Koeffler HP and Bang YJ: Alterations of p16 INK4A and INK4B genes in gastric carcinomas. Cancer 80: 1889-1896, 1997.
14. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC and Sung JJ: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102: 623-628, 2002.
15. Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ and To KF: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002.
16. Tascilar M, Skinner HG, Rostly C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, Yeo EJ, Hruban RH and Goggins M: The Smad4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7: 4115-4121, 2001.
17. Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA and Powell SM: Allelotype of gastric adenocarcinoma. Cancer Res 59: 1437-1441, 1999.
18. Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM, Giardiello FM, Tinsley ST, Aaltonen LA and Lynch HT: The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B and ACVR1 mutations. J Med Genet 41: 484-491, 2004.
19. Feng XH, Lin X and Derynck R: Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15INK4B transcription in response to TGF-β. EMBO J 19: 5178-5193, 2000.
20. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
21. Xiangming C, Natsugoe S, Takao S, Hokita S, Ishigami S, Tanabe G, Baba M, Kuroshima K and Aikou T: Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res 7: 277-282, 2001.
22. Kim JY, Park DY, Kim GH, Choi KU, Lee CH, Huh GY, Sol MY, Song GA, Jeon TY, Kim DH and Sim MS: Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma. Histol Histopathol 20: 543-549, 2005.
23. Okano H, Shinohara H, Miyamoto A, Takaori K and Tanigawa N: Concomitant overexpression of cyclooxygenase-2 in Her-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome. Clin Cancer Res 10: 6938-6945, 2004.
24. Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, Kim SJ, Lee KU, Choe KJ and Yang HK: Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol 15: 574-580, 2004.
25. Lee HS, Lee HK, Kim HS, Yang HK and Kim WH: Tumor suppressor gene expression correlates with gastric cancer prognosis. J Pathol 200: 39-46, 2003.
26. Bachman KE and Park BH: Dual nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17: 49-54, 2005.
27. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S and Sugimachi K: Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17: 607-614, 1999.
28. Kuga H, Morisaki T, Nakamura K, Onishi H, Noshiro H, Uchiyama A, Tanaka M and Katano M: Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 22: 7838-7847, 2003.
29. Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000.
30. Lei J, Zou TT, Shi YQ, Zhou X, Smolinski KN, Yin J, Souza RF, Appel R, Wang S, Cymes K, Chan O, Abbraham JM, Harpaz N and Meltzer SJ: Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 13: 2459-2462, 1996.
31. van Rees BP, Caspers E, zur Hausen A, van den Brule A, Drillenburg P, Weterman MA and Offerhaus GJ: Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am J Pathol 161: 1207-1213, 2002.
32. Powell SM, Harper JC, Hamilton SR, Robinson CR and Cummings OW: Inactivation of Smad4 in gastric carcinomas. Cancer Res 57: 4221-4242, 1997.